DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Vermorken JB, Trigo J, Hitt R, Koralewski P, Diaz-rubio E, Rolland F, Knecht R, Amellal N, Schueler A, Baselga J.
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
J Clin Oncol 2007; Jun 1;
25 (16) 2171-2177
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.